What is Clarametyx Biosciences's official website?

Clarametyx Biosciences's website is clarametyx.com

How many employees are working in Clarametyx Biosciences right now?

Clarametyx Biosciences has 22 employees.

What is Clarametyx Biosciences's industry?

Clarametyx Biosciences's industry is Biotechnology Research

Who are Clarametyx Biosciences's top competitors?

Clarametyx Biosciences's top competitors are , , , , , ,

Clarametyx Biosciences company information, Employees & Contact Information

Explore related pages

Clarametyx Biosciences email format Clarametyx Biosciences management contacts

Related company profiles:

Clarametyx Biosciences Inc. is a clinical stage biotechnology company developing immune-enabling biologic therapies to fight life-threatening infections. Our novel technology platform targets the protective barrier around bacteria, known as biofilms.

Employees: 22
Founded: -
Address: 1275 Kinnear Rd, Columbus,ohio 43212,united States
Phone: 614.686.2689
Email: in****@****tyx.com
Industry: Biotechnology Research
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)
Website: clarametyx.com
Keywords: biotechnology, antibiotics, antibiotic resistance, biofilms, infectious disease.
HQ: Columbus, Ohio
Competitors: Cleveland Diagnostics, Sarepta Therapeutics, Neucore Bio, Armatus Bio, Inc., Abeona Therapeutics, Forge Biologics, Basking Biosciences Inc, Andelyn Biosciences, Ohio Life Sciences Association, Vertex Pharmaceuticals.

Clarametyx Biosciences Questions

News

Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress - Business Wire

Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress Business Wire

Clarametyx completes enrolment in cystic fibrosis trial - Clinical Trials Arena

Clarametyx completes enrolment in cystic fibrosis trial Clinical Trials Arena

Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis - Business Wire

Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis Business Wire

Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2A Study Evaluating CMTX-101 for Infections Associated With Cystic Fibrosis - BioSpace

Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2A Study Evaluating CMTX-101 for Infections Associated With Cystic Fibrosis BioSpace

Clarametyx Biosciences Announces FDA Grant of Fast Track and Qualified Infectious Disease Product Designations for CMTX-101 - Yahoo Finance

Clarametyx Biosciences Announces FDA Grant of Fast Track and Qualified Infectious Disease Product Designations for CMTX-101 Yahoo Finance

Nationwide Children's spinoff targeting antibiotic resistance starts developing vaccine - The Business Journals

Nationwide Children's spinoff targeting antibiotic resistance starts developing vaccine The Business Journals

Clarametyx to advance trial of CMTX-101 with DMC approval - Clinical Trials Arena

Clarametyx to advance trial of CMTX-101 with DMC approval Clinical Trials Arena

FDA fast-tracks antibody treatment targeting bacterial biofilms - CIDRAP

FDA fast-tracks antibody treatment targeting bacterial biofilms CIDRAP

Innovators in Healthcare and Life Sciences Awards: Clarametyx Biosciences - Columbus Business First - The Business Journals

Innovators in Healthcare and Life Sciences Awards: Clarametyx Biosciences - Columbus Business First The Business Journals

FDA Fast Tracks Antibody Therapy for Pulmonary Infections Including Cystic Fibrosis - Contagion Live

FDA Fast Tracks Antibody Therapy for Pulmonary Infections Including Cystic Fibrosis Contagion Live

CF trial completes enrollment, nears top-line results for lung infections - Cystic Fibrosis News Today

CF trial completes enrollment, nears top-line results for lung infections Cystic Fibrosis News Today

Clarametyx Biosciences Announces Investment by Kineticos AMR Accelerator Fund - Business Wire

Clarametyx Biosciences Announces Investment by Kineticos AMR Accelerator Fund Business Wire

Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients - Contagion Live

Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients Contagion Live

FDA puts CMTX-101 on fast track for treating CF lung infections - Cystic Fibrosis News Today

FDA puts CMTX-101 on fast track for treating CF lung infections Cystic Fibrosis News Today

Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections - Business Wire

Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections Business Wire

Clarametyx launches Phase Ib/IIa cystic fibrosis therapy trial - Clinical Trials Arena

Clarametyx launches Phase Ib/IIa cystic fibrosis therapy trial Clinical Trials Arena

Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections - Business Wire

Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections Business Wire

CARB-X funds development of anti-biofilm vaccine - CIDRAP

CARB-X funds development of anti-biofilm vaccine CIDRAP

Charlotte Rogers Obituary July 10, 2025 - newcomerdayton.com

Charlotte Rogers Obituary July 10, 2025 newcomerdayton.com

FDA accepts IND application for Clarametyx antibody therapy CMTX-101 - Drug Target Review

FDA accepts IND application for Clarametyx antibody therapy CMTX-101 Drug Target Review

Companies like Clarametyx Biosciences

Top Clarametyx Biosciences Employees

Michael Triplett

Founder | Innovator | Director

Columbus, Ohio, United States, United States

View

8
stasco-mech.com, osu.edu, insightpartners.com, carmenpartners.com, myonexustx.com, n8medical.com, armatusbio.com, myonexustx.com

1 (614) 4XXXXXXX
Emma Scharfenberger Off

Ceo & President | Investor | Attorney | Board Member | M&A | Strategist | Innovation And Venture Capital At Cincytech

Cincinnati, Ohio, United States, United States

View
Juliana Woda

Senior Director, Innovations At Cleveland Clinic

Greater Cleveland, United States

View

5
gmail.com, athersys.com, athersys.com, ccf.org, clevelandclinic.org

2 +121628XXXXX
Bill Baumel

Silicon Valley & Midwest Vc

Columbus, Ohio, United States, United States

View

7
ohioinnovationfund.com, hotmail.com, gmail.com, rwiventures.com, domedia.com, rwigroup.com, brinsonpartners.com

2 +140855XXXXX

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles

Get direct phone numbers & mobile contacts

Access company data & employee information

Works directly on LinkedIn - no copy/paste needed

Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Learn More

How It Works

Get a Free Account

Search the #1 Contact Database

Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.

Use our AI-Powered Email Finder

Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.

Have a look at Aeroleads Data

Browse our Data

Company Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Profile Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

List Search

a b c d e f g h i j k l m n o p q r s t u v w x y z

Clarametyx Biosciences company information, Employees & Contact Information

Explore related pages

Company Details

Clarametyx Biosciences Questions

What is Clarametyx Biosciences's helpline number?

What is Clarametyx Biosciences's official website?

What is Clarametyx Biosciences's LinkedIn profile?

How many employees are working in Clarametyx Biosciences right now?

What is Clarametyx Biosciences's industry?

What are Clarametyx Biosciences's top competitors?

What is Clarametyx Biosciences's support email address?

What are Clarametyx Biosciences's categories?

When was Clarametyx Biosciences founded?

News

Clarametyx Biosciences Strengthens Leadership Team to Accelerate Pipeline and Corporate Development Progress - Business Wire

Clarametyx completes enrolment in cystic fibrosis trial - Clinical Trials Arena

Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis - Business Wire

Clarametyx Biosciences Announces Positive Interim Analysis in Phase 2A Study Evaluating CMTX-101 for Infections Associated With Cystic Fibrosis - BioSpace

Clarametyx Biosciences Announces FDA Grant of Fast Track and Qualified Infectious Disease Product Designations for CMTX-101 - Yahoo Finance

Nationwide Children's spinoff targeting antibiotic resistance starts developing vaccine - The Business Journals

Clarametyx to advance trial of CMTX-101 with DMC approval - Clinical Trials Arena

FDA fast-tracks antibody treatment targeting bacterial biofilms - CIDRAP

Innovators in Healthcare and Life Sciences Awards: Clarametyx Biosciences - Columbus Business First - The Business Journals

FDA Fast Tracks Antibody Therapy for Pulmonary Infections Including Cystic Fibrosis - Contagion Live

CF trial completes enrollment, nears top-line results for lung infections - Cystic Fibrosis News Today

Clarametyx Biosciences Announces Investment by Kineticos AMR Accelerator Fund - Business Wire

Clarametyx Biosciences Initiates Phase 2a Trial for CMTX-101 in Cystic Fibrosis Patients - Contagion Live

FDA puts CMTX-101 on fast track for treating CF lung infections - Cystic Fibrosis News Today

Clarametyx Biosciences Awarded a Multi-Phased Agreement With CARB-X to Accelerate Anti-Biofilm Vaccine to Prevent Bacterial Infections - Business Wire

Clarametyx launches Phase Ib/IIa cystic fibrosis therapy trial - Clinical Trials Arena

Clarametyx Biosciences Announces $33M Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections - Business Wire

CARB-X funds development of anti-biofilm vaccine - CIDRAP

Charlotte Rogers Obituary July 10, 2025 - newcomerdayton.com

FDA accepts IND application for Clarametyx antibody therapy CMTX-101 - Drug Target Review

Companies like Clarametyx Biosciences

Vertex Pharmaceuticals

Basking Biosciences Inc

Ohio Life Sciences A...

Neucore Bio

Abeona Therapeutics

Armatus Bio, Inc.

Forge Biologics

Cleveland Diagnostics

Andelyn Biosciences

Sarepta Therapeutics

Top Clarametyx Biosciences Employees

Michael Triplett

Founder | Innovator | Director

Emma Scharfenberger Off

Ceo & President | Investor | Attorney | Board Member | M&A | Strategist | Innovation And Venture Capital At Cincytech

Juliana Woda

Senior Director, Innovations At Cleveland Clinic

Bill Baumel

Silicon Valley & Midwest Vc

Free Chrome Extension

Aero Online

Select data to include:

How It Works

Get a Free Account

Search the #1 Contact Database

Use our AI-Powered Email Finder

Have a look at Aeroleads Data